Dr. Lal PathLabs Limited (NSE:LALPATHLAB)
1,648.00
-1.80 (-0.11%)
May 11, 2026, 3:30 PM IST
Dr. Lal PathLabs Balance Sheet
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Cash & Equivalents | 9,095 | 2,926 | 3,609 | 2,637 | 3,782 |
Short-Term Investments | 4,226 | 5,448 | 4,679 | 4,006 | 2,380 |
Trading Asset Securities | - | 3,267 | 1,138 | 1,499 | 654.59 |
Cash & Short-Term Investments | 13,321 | 11,641 | 9,426 | 8,143 | 6,817 |
Cash Growth | 14.44% | 23.50% | 15.75% | 19.46% | -30.73% |
Accounts Receivable | 1,107 | 881.21 | 774.02 | 708.24 | 853.95 |
Other Receivables | - | 345.81 | 314.73 | 215.9 | 199.29 |
Receivables | 1,125 | 1,238 | 1,102 | 937.78 | 1,064 |
Inventory | 439 | 361.32 | 373.07 | 338.06 | 525.41 |
Prepaid Expenses | - | 163.04 | 164.2 | 127.92 | 139 |
Restricted Cash | - | - | - | - | 1.43 |
Other Current Assets | 781 | 231.75 | 202.23 | 184.02 | 205.2 |
Total Current Assets | 15,666 | 13,635 | 11,267 | 9,731 | 8,752 |
Property, Plant & Equipment | 4,893 | 3,393 | 3,470 | 4,040 | 4,298 |
Goodwill | 5,482 | 5,481 | 5,482 | 5,478 | 5,434 |
Other Intangible Assets | 1,925 | 2,511 | 3,043 | 3,582 | 4,106 |
Long-Term Deferred Tax Assets | 875 | 866.16 | 448.59 | 404.24 | 370.38 |
Other Long-Term Assets | 2,618 | 1,282 | 849.02 | 619.97 | 506.42 |
Total Assets | 31,460 | 27,168 | 24,560 | 23,856 | 23,468 |
Accounts Payable | 1,806 | 1,988 | 1,866 | 1,561 | 1,474 |
Accrued Expenses | 738 | 567.49 | 486.68 | 405.41 | 409.63 |
Short-Term Debt | - | - | - | 700.04 | 955.2 |
Current Portion of Long-Term Debt | - | - | 833.34 | 833.33 | 833.33 |
Current Portion of Leases | 536 | 547.94 | 605.77 | 528.35 | 480.56 |
Current Income Taxes Payable | 71 | 138.47 | 132.86 | 4.97 | 31.56 |
Current Unearned Revenue | - | 123.45 | 116.59 | 97.19 | 94.92 |
Other Current Liabilities | 1,356 | 657.69 | 594.91 | 567.24 | 720.84 |
Total Current Liabilities | 4,507 | 4,024 | 4,636 | 4,698 | 5,000 |
Long-Term Debt | - | - | - | 833.34 | 1,668 |
Long-Term Leases | 1,454 | 1,026 | 1,030 | 1,300 | 1,389 |
Pension & Post-Retirement Benefits | 26 | 19.47 | 16.06 | - | - |
Long-Term Deferred Tax Liabilities | 60 | 33.73 | 23.92 | 29.41 | 40.39 |
Total Liabilities | 6,047 | 5,103 | 5,706 | 6,860 | 8,097 |
Common Stock | 1,676 | 835.92 | 834.78 | 833.68 | 833.45 |
Additional Paid-In Capital | - | 1,248 | 1,049 | 934.88 | 927.95 |
Retained Earnings | - | 20,054 | 17,025 | 14,531 | 12,935 |
Treasury Stock | - | -194.81 | -143.9 | -118.53 | -161.72 |
Comprehensive Income & Other | 23,406 | -216.13 | -271.61 | 482.24 | 481.3 |
Total Common Equity | 25,082 | 21,727 | 18,493 | 16,663 | 15,016 |
Minority Interest | 331 | 337.63 | 360.81 | 332.47 | 354.6 |
Shareholders' Equity | 25,413 | 22,065 | 18,854 | 16,995 | 15,371 |
Total Liabilities & Equity | 31,460 | 27,168 | 24,560 | 23,856 | 23,468 |
Total Debt | 1,990 | 1,574 | 2,469 | 4,195 | 5,326 |
Net Cash (Debt) | 11,331 | 10,066 | 6,957 | 3,948 | 1,491 |
Net Cash Growth | 12.56% | 44.70% | 76.20% | 164.81% | -82.11% |
Net Cash Per Share | 67.79 | 60.34 | 41.79 | 23.75 | 8.99 |
Filing Date Shares Outstanding | 167.05 | 166.73 | 166.43 | 165.88 | 165.52 |
Total Common Shares Outstanding | 167.05 | 166.73 | 166.43 | 165.88 | 165.52 |
Working Capital | 11,159 | 9,612 | 6,631 | 5,033 | 3,752 |
Book Value Per Share | 150.15 | 130.31 | 111.12 | 100.45 | 90.72 |
Tangible Book Value | 17,675 | 13,735 | 9,968 | 7,603 | 5,476 |
Tangible Book Value Per Share | 105.81 | 82.38 | 59.89 | 45.83 | 33.08 |
Land | - | 109.57 | 109.57 | 109.57 | 109.57 |
Buildings | - | 554.71 | 554.71 | 554.44 | 548.34 |
Machinery | - | 3,615 | 3,288 | 3,046 | 2,757 |
Construction In Progress | - | 34.76 | 39.51 | 29.67 | 144.48 |
Leasehold Improvements | - | 743.43 | 679.93 | 581.31 | 494.38 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.